PDS Biotechnology Valuation

PDSB Stock  USD 3.85  0.63  14.06%   
At this time, the company appears to be undervalued. PDS Biotechnology Corp holds a recent Real Value of $8.12 per share. The prevailing price of the company is $3.85. Our model determines the value of PDS Biotechnology Corp from inspecting the company fundamentals such as Shares Outstanding of 31.11 M, return on asset of -0.49, and Return On Equity of -1.43 as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors support taking in undervalued entities and trading overvalued entities since, at some point future time, asset prices and their ongoing real values will merge together.
Price Book
5.692
Enterprise Value
108.7 M
Enterprise Value Ebitda
(2.24)
Undervalued
Today
3.85
Please note that PDS Biotechnology's price fluctuation is slightly risky at this time. Calculation of the real value of PDS Biotechnology Corp is based on 3 months time horizon. Increasing PDS Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for PDS Biotechnology Corp is useful when determining the fair value of the PDS stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of PDS Biotechnology. Since PDS Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PDS Stock. However, PDS Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  3.85 Real  8.12 Target  19.14 Hype  4.48 Naive  4.43
The real value of PDS Stock, also known as its intrinsic value, is the underlying worth of PDS Biotechnology Corp Company, which is reflected in its stock price. It is based on PDS Biotechnology's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of PDS Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PDS Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
8.12
Real Value
13.08
Upside
Estimating the potential upside or downside of PDS Biotechnology Corp helps investors to forecast how PDS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PDS Biotechnology more accurately as focusing exclusively on PDS Biotechnology's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.49-0.42-0.3
Details
Hype
Prediction
LowEstimatedHigh
0.224.489.44
Details
Naive
Forecast
LowNext ValueHigh
0.094.439.38
Details
7 Analysts
Consensus
LowTarget PriceHigh
17.4219.1421.25
Details

PDS Biotechnology Investments

300,439

PDS Biotechnology Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining PDS Biotechnology's current stock value. Our valuation model uses many indicators to compare PDS Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PDS Biotechnology competition to find correlations between indicators driving PDS Biotechnology's intrinsic value. More Info.
PDS Biotechnology Corp is regarded fourth in net asset category among related companies. It is regarded third in beta category among related companies . The ratio of Net Asset to Beta for PDS Biotechnology Corp is about  44,590,575 . Comparative valuation analysis is a catch-all model that can be used if you cannot value PDS Biotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for PDS Biotechnology's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PDS Biotechnology's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PDS Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PDS Biotechnology and how it compares across the competition.

About PDS Biotechnology Valuation

The stock valuation mechanism determines the current worth of PDS Biotechnology Corp on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of PDS Biotechnology Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of PDS Biotechnology Corp based exclusively on its fundamental and basic technical indicators. By analyzing PDS Biotechnology's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of PDS Biotechnology's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of PDS Biotechnology. We calculate exposure to PDS Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PDS Biotechnology's related companies.
Last ReportedProjected for 2024
Gross Profit-44.2 K-46.4 K
Pretax Profit Margin 0.00  0.00 
Operating Profit Margin 0.00  0.00 
Net Profit Margin 0.00  0.00 
Gross Profit Margin 0.00  0.00 

8 Steps to conduct PDS Biotechnology's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PDS Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PDS Biotechnology's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain PDS Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine PDS Biotechnology's revenue streams: Identify PDS Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research PDS Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish PDS Biotechnology's growth potential: Evaluate PDS Biotechnology's management, business model, and growth potential.
  • Determine PDS Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PDS Biotechnology's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

PDS Biotechnology Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as PDS Biotechnology does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding28.6 M

PDS Biotechnology Current Valuation Indicators

Valuation refers to the process of determining the present value of PDS Biotechnology Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value PDS we look at many different elements of the entity such as PDS's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. PDS Biotechnology's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final PDS Biotechnology's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PDS Biotechnology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PDS Biotechnology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PDS Biotechnology's worth.
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for PDS Stock analysis

When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is PDS Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.71)
Return On Assets
(0.49)
Return On Equity
(1.43)
The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.